
Ncardia and LUMC Develop Automated Human Cardiac Microtissue Platform
Published on January 22, 2026
Ncardiahas collaborated with Leiden University Medical Center (LUMC)on the development of an automated human cardiac microtissue platform for large-scale drug screening. The work has been published in Trends in Biotechnology and is a joint effort to improve the speed, reliability, and translational relevance of early-stage cardiac drug discovery.
